Finished Products


Neopharma today has 6 state-of-the-art manufacturing sites (API & Finished Dose) globally. We have ensured world-class quality in design, equipment and operations in all our manufacturing facilities across the world. With the first manufacturing facility started in UAE, Neopharma now has units in USA, Brazil, India, Japan along with additional units in UAE. Our units ensure that we are able to provide best-in-class products to patients across 50 countries worldwide.

Our manufacturing operations are focused on producing generics, branded generics, specialty, over-the-counter (OTC) products, oncology.

Neopharma’s commitment to quality and state of the art manufacturing facilities base has led to manufacturing partnerships with major global pharmaceutical companies such as Pfizer, Merck, GSK, Lagap, Abbott among many others.

Neopharma UAE


  • Total area of 51,000 sq. meters
  • Two independent production blocks
  • Dedicated general product manufacturing
  • Exclusive block for Beta - Lactam manufaturing
  • Modular Manufacturing
  • Unidirectional flow of work process
  • cGMP certified facility

Neopharma Japan


  • Facility established by Nippon Roche Co.
  • Manufacturing using patented fermentation technology
  • Total area of 118,000 sq. meters.
  • Development and manufacturing of finished products, API and intermediates containing 5 - ALA
  • cGMP certified facility
Click here know more

Omnicare Drugs


  • Proposed OSD, liquid Oral & Ointment Facility at Vizag (Area 12 acres)
  • State of the Art facility with modern technology
  • To comply with local GMP norms, USFDA and PMDA, Japan.
  • Capacity: 2.3 Billion Tablets/Capsules

NeoAska Pharma


  • Proposed JV facility between Omnicare Drugs, India and ASKA Pharmaceuticals Japan
  • Manufacturing products related to chronic therapies CVS, CNS, Diabetes
  • Planned EUGMP, USFDA, PMDA Approvals
  • Oral solid dosage forms, liquids, topical preparations.

Neopharma USA


  • 25,000 sq. ft development facility with laboratory and pilot plant equipment
  • Dedicated oral penicillin manufacturing facility
  • 8 bottle and blister packing lines
  • USFDA approved

Neopharma Brazil


  • Total green area : 13,700 sq meters.
  • Manufacturing facility:6,000 sq. meters.
  • 2 production blocks (API & Finished Product Manufacturing)
  • Manufacturing solid & semisolid dosage form
  • ANVISA approved facility
TOP